Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Batrachochytrium dendrobatidis is a non-hyphal parasitic chytrid fungus that infects amphibians worldwide and is the causative agent of chytridiomycosis. This disease has led to dramatic declines and extinctions in hundreds of amphibian species globally. The fungus primarily infects the keratinized skin layers of adult amphibians and mouthparts of tadpoles. It spreads through motile zoospores in water or by direct contact between hosts. Infection disrupts skin function—critical for gas exchange and electrolyte balance in amphibians—leading to lethargy, abnormal behavior, thickening of the skin, electrolyte imbalance (notably sodium and potassium loss), cardiac arrest, and death in susceptible species[1][2][3][5]. While some species are resistant carriers, others experience mass mortality events. There are no known drugs approved for environmental eradication or large-scale treatment; management focuses on biosecurity measures to prevent spread[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Batrachochytrium dendrobatidis (Bd).